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ABSTRACT
Human skin as test substrate in the indirect immunofluorescent test has been found
to be superior to rabbit esophagus in that it is considerably more sensitive for the
detection of antiepithelial antibodies. By using horizontal skin sections rather than
conventional vertical sections, the accuracy and reliability of the test has been greatly
enhanced. The test technique which we describe is simple to perform, and yields re-
producible results.
There was a good correlation between the initial serum antiepithelial antibody titer
and the activity of disease in patients with pemphigus and bullous pemphigoid. In
following the course of the disease in five patients the activity of the skin affection was
usually reflected by the serum antibody levels.
In 1964, Beutner and Jordon, using the in-
direct immunofluorescent technique, demon-
strated that sera of patients with pemphigus
vulgaris contain antibodies which in vitro bind
to heterologous and homologous stratified
squamous epithelia (1). This observation has
been confirmed many times (2—5). Jordon et al.
later demonstrated in sera of patients with
bullous pemphigoid (pemphigoid) antibodies
which bind to the basement membrane area of
heterologous, homologous, and autologous strat-
ified epithelia (6). The antibodies present in
sera from patients with pemphigus or bullous
pemphigoid are specific for the respective dis-
eases and yield typical immunofluorescent pat-
terns in the in vitro tests.
Animal stratified squamous epithelia rather
than human skin has been the preferred sub-
strate for detecting antiepithelial antibodies
with the indirect immunofluorescent test. Some
of the problems of using human skin as the
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substrate are: nonspecific fluorescence of the
stratum corneum and dermis, quenching of im-
munofluorescence by skin with a high melanin
content, and the need to use acanthotic
epidermis (2). In this paper we describe a sim-
ple indirect immunofluorescent test technique
which utilizes human skin as the substrate and
obviates the problems noted above by cutting
the skin sections horizontally. In the technique
described we also use commercially available
fluorescein tagged antihuman immunoglobulin.
MATERIALS AND METHODS
Clinical diagnosis. The diagnosis of pemphigus
was established by clinical examination and either
by histologic examination of biopsy material or
by the presence of acantholytic cells in Tzanck
preparations. The diagnosis of pemphigoid was
made by clinical examination, histologic examina-
tion of biopsy material, and by the patient's
failure to resuond to dapsone or sulfapyridine
treatment. A drug reaction was excluded through
history. A bullous skin eruption associated with
malignancies was excluded by physical examina-
tion, laboratory tests and x-ray examinations.
Diagnosis of dermatitis herpetiformis (D.H.) was
made by clinical examination, compatible his-
tology, and responsiveness to dapsone or sulfa-
pvridine (7).
Preparations of tissue sections. Six millimeter
punch biopsies were obtained either from normal
skin of human volunteers or from six to 24 hour
old human cadavers. For comparative studies the
mucosa of the upper halves of rabbit esophagi
was also used. The skin and the rabbit esophagi
were frozen and stored in liquid nitrogen for up to
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PREPARATION OF TISSUE SECTIONS
Fin. 1
Fin. 2. Hematoxylin and eosin stain of human skin cut horizontally (parallel to skin
surface).
one week. For sectioning in a cryostat they were
embedded in OCT* media. Four micron thick
horizontal (parallel to skin surface) sections were
made from the skin and equal but transverse sec-
tions were made from the esophagi .(Figs. 1 and 2).
From each tissue sample about 100 sections were
made. The sections were placed on glass slides
and were either used on the same day or stored
at —20° C. for use at a later time. Before use, the
slides with the tissue sections were thawed and
kept at room temperature for ½ to 1½ hours.
Immuno fluorescent technique. Sera from pa-
tients with pemphigus, pemphigoid, and other skin
diseases were kept frozen at —20° C. For testing,
the thawed sera were diluted serially with isotonic
saline starting with a 1:10 dilution. Undiluted
sera were not used because they were often found
to yield an unspecific epidermal fluorescence. The
antibody titer is defined as the highest dilution of
* Ames Company, Elkhart, Indiana.
a serum which still gives a positive immuno—
fluorescent test. For control purposes positive and
negative control sera were always run with the
unknown samples.
The indirect immunofluorescent staining tech-
nique of Weller and Coons (8) was used. The
tissue section on the glass slide was covered with
one to two drops of the serum dilutions and in-
cubated at room temperature in a moist chamber
for 30 mins. The serum was removed from the
tissue section by immersion into three to four
changes of a 0.15 M sodium phosphate buffer (pH
7.3) for 45 mins. The rinsed section was covered
with one to two drops of fluorescein isothio-
cyanate tagged goat antiserum to human immuno-
globulin (Ig)G, M or A.t (After reconstitution of
the lyophilized antisera they were used in a 1: III
dilution made with phosphate buffer.) The tissue
section was incubated at room temperature in a
t Hyland Laboratory, Los Angeles, California.
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FIG. 3
moist chamber for 30 mins. The section was then
washed again for 45 minutes with phosphate buffer
and was covered with a drop of phosphate buffered
glycerol (1:1 pH 7.3) and a cover slip applied.
The slides were studied for immunofluorescence
under ultraviolet light using a Leitz Orthoplan
microscope (Fig. 3), The filters consisted of a
BG-38 beat filter, a BG-12 exciter ifiter and a
K-530 barrier filter.
Affinity of human skin and rabbit esophageal
Inucosa for antiepithelial antibodies. In order to
assess the antibody affinity of human skin in com-
parison to rabbit esophageal mucosa many sera
were tested several times using the same and dif-
ferent epithelia.
The stability of the epithelial antigens was
determined on fresh sections of skin (including
cadaver skin up to 24 hours old) and rabbit
esophagus after storage of the sections at —20° C.
for various periods at time.
The sensitivity of human skin and rabbit eso-
phageal mucosa was determined by using four sera
with known low autoantibody titers.
Reproducibility of the test. To determine the
reproducibility of the test, immunofluorescent
tests were performed with several sara using skin
from different people and esophagi from different
rabbits.
Two and occasionally three investigators inter-
preted the immunofluorescent pattern.
Stability of the stained slides. The presence or
the absence of specific immunofluorescence was
assessed immediately after performing the test.
The slides were then kept at 4°—8° C. and checked
for loss or fading of immunofluorescence at various
time intervals.
Properties of the commercially prepared fluore-
scein tagged anti.sera. The molar fluorescein to
protein ratios in the commercially obtained anti-
human immunoglobulin preparations were deter-
mined with the method of Wells, Miller, and
Nadel (9). The specificity of the antisera for
gamma M, G, and A class of human antibodies
was assayed by immunoelectrophoresis, The speci-
ficity of the immunofluorescent reaction was
assessed by blocking experiments. The tissue sec-
tions, after having bound antiepithelial antibodies,
were first incubated with unlabeled goat anti-
human IgG and subsequently with the labeled goat
anti-human IgG.
Correlation between diseoae activity and anti-
body titer. Initial autoantibody titers were deter-
mined with the sera of 25 patients with pemphigus
and pemphigoid. The titers were correlated with
the clinical activity of the disease. Also, five pa-
tients were observed during treatment and sequen-
tial titers were determined. When comparing sera
titers in a given patient during the course of the
disease all serum samples were tested simulta-
neously on the same epithelial tissue.
RESULTS
1. Accuracy of the immuno fluorescent test
The sera of 165 patients with bullous and
non-bullous diseases were tested for the pres-
ence or absence of antiepithelial antibodies.
Normal human skin was used as the substrate.
Figure 4 demonstrates the immunofluorescent
staining pattern obtained with sara from pa-
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FIG. 4. Positive indirect immunofluorescent staining of epidermal cell boundaries using
a 1:20 dilution of a serum from a patient with pemphigus. Stratum corneum at left.
FIG. 5. Positive indirect immunofluorescent staining of basement membrane area of
human skin using a 1:40 dilution of a serum from a patient with bullous pemphigoid.
Dermis at bottom. Circle is immunofluorcscence of basement membrane surrounding a
dermal papilla (cut horizontally).
tients with pemphigus. The immunofluorescence
outlines the boundaries of the epidermal cells
("pemphigus type"). Figure 5 shows the fluo-
rescent staining of the basement membrane
area which was obtained with the serum of a
patient with bullous pemphigoid ("pemphigoid
type"). In Figure 6 the nuclei of the epithelial
cells fluoresce. The serum which induced this
reaction was from a patient with lupus cry-
thematosus.
4
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Ftc. 6. Positive indirect immunofluorescent staining of epidermal cell nuclei using a
1:20 dilution of a serum from a patient with systemic lupus erythematosus. Stratum
corneum at left.
The results of our tests with the sera from
165 patients are summarized in Table I. Two
sera of 114 patients with nonvesiculobullous
diseases contained antinuclear antibodies. None
of the following sera contained antiepithelial
antibodies: 12 from patients with dyshidrosi-
form or viral eruptions, six from patients with
bullous erythema multiforme, five from patients
with dermatitis herpetiformis, two from pa-
tients with Hailey-Hailey disease, and one
from a patient with Darier's disease. Of 17 pa-
tients with pemphigus, 14 had serum anti-
bodies which were bound to the epidermal cell
boundaries of normal human skin. None of the
pemphigus patients had antibodies which
reacted with the basement membrane area.
Seven of eight sera from patients with bullous
pemphigoid had basement membrane anti-
bodies. All antiepithelial antibodies (pemphigus,
pemphigoid) were of the gamma 0 class. One
serum of a patient with lupus erythematosus
contained antinuclear antibodies of the gamma
A class.
2. Affinity of human skin and rabbit esopha-
geal mucosa for antiepithelial antibodies
a) Stability. The reactivity with antiepithe-
hal antibodies of the "pemphigus type" was
maintained in skin sections which had been
kept for five weeks at —20° 0. but had disap-
peared in rabbit esophagus sections kept for
two weeks at this temperature. The reactivity
with antiepithelial antibodies of the "pemphi-
goid type" was preserved in skin and esoph-
agus for five and two weeks respectively.
b) Sensitivity. Four sera (Table II) with
low antiepithelial antibody titers yielded nega-
tive immunofluorescent tests when rabbit
esophageal mueosa was used. These tests were
positive when human skin was used. None of
the four sera from patients with pemphigus and
pemphigoid which yielded negative tests when
human skin was used, yielded positive tests
with rabbit esophageal mucosa.
3. Reproducibility of the test
a) Variability of different specimens of hu-
man skin and rabbit esophagus. Sera tested
several times using the same as well as different
human skin showed that the highest serum
dilutions which yielded a positive test were
generally of the same order but were not
identical each time they were tested. They
usually varied by not more than one dilution
but occasionally they varied by two dilutions
(Table III). For example, serum A (Table
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TABLE I
Results of indirect immunofluorescent test using
normal human skin as substrate
Diagnosis No.
Base-
ment
mem-
brane
area
Strati-
fled
epi-
thelial
cell
bound-
aries
Epi-
thelial
cell
nuclei
Control (nonvesicu-
lobullous diseases)
Pemphigus
Bullous pemphigoid
Bullous E. M.
Hailey-Hailey
Darier's
Dermatitis herpeti-
formis
Other vesiculobullous
disease (including
dyshidrosiform and
viral eruption)
114
17
8
6
2
1
5
12
0
0
7
0
0
0
0
0
0
14
0
0
0
0
0
0
2
0
0
0
0
0
0
0
TABLE II
Comparison of sensitivity of fresh human. skin and
rabbit esophagus for the detection of antiepithelial
antibodies
Sera
"Pemphigus
antibodies"
Skin Esophagus
'Pentphigoid
antibodies"
Skin Esophagus
M
N
0
P
20*
10
Neg
Neg
20
20
Neg
Neg
* Highest dilution which yielded a positive test.
TABLE III
Antiepithelial antibody titers obtained with skin.
from different sources
Sera
•Skin from different
sources
Two skin
specimens
from same
donor
1 2 3 4 5 6 SA
A 320* 320 160 160 80 160 320
B 160 160 160 160 320
C 160 160 320 160 320 640
D 320 80 160
* Highest dilution which yielded a positive test.
III) yielded a positive immunofluorescent test
at a 320 fold dilution and serum C yielded a
positive immunofluorescent test at a 160 fold
dilution when skin Specimen 1 was used. How-
ever, when skin specimen 6 was used serum A
yielded a positive immunofluorescent test at a
160 fold dilution and serum C a 320 fold dilu-
tion. There was no significant difference in the
results when Negro skin was used.
Determinations made with several sera and
using the same as well as different rabbit
esophagi showed that the highest serum dilution
yielding a positive test usually varied by not
more than one dilution and only occasionally
by two dilutions (Table IV).
b) Determination of the serum antibody
titer by different investigators. When several
observers evaluated the tests they differed fre-
quently about one dilution variation in their in-
terpretation of a positive or a negative test and
only very rarely did observers differ in inter-
pretation by two dilutions.
4. Stability of the stained slides
When titers were determined immediately
after fluorescein staining and then left in the
refrigerator the immunofluoreseence did not
fade for as long as one week.
5. Properties of commercially
labeled antisera
The molar fluorescein to protein ratios of the
various antisera were between 3.5 and 4.5
which indicates an optimal binding of fibres-
cein isothiocyanate to the protein. Immuno-
electrophoretic analyses yielded a single line of
precipitation when the antisera were tested
with normal human sera. Previous incubation
TABLE IV
Antiepithelial antibody titers obtained with esophagi
from different sources
Specimens from
same rabbit
Specimens from
different rabbits
Sera
1 2 3 4
A* 40t 40 160 80
B* 20 40 80 80
C* 80 80 160
* Same as A, B, and C in Table 3.
t Highest dilution which yielded a positive test.
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of the tissue sections with unlabeled goat anti-
human IgG prevented detectable binding of
fluorescent anti-human IgG.
6. Correlation between disease activity
and antibody titer
a) Initial antiepithelial antibody titers and
disease activity. All sera from patients with
active pemphigus or pemphigoid yielded a
positive immunofluorescent test. With one ex-
ception patients with widespread active dis-
ease (pemphigus and pemphigoid) uniformly
demonstrated serum antiephithelial antibody
titers of 1: 160 or higher. Patients with moder-
ate involvement had serum antibody titers of
1:20 and higher. Patients with localized disease
(especially mouth lesions) had serum titers of
1:10 or 1:20. Patients under adequate therapy
with corticosteroids or in remission had low an-
tibody titers or negative immunofluorescent
tests (TabbY).
b) Sequential antiepithelial antibody titers
correlated with changes in clinical activity. One
patient with widespread bullous pemphigoid
and an initial serum titer of "pemphigoid type"
TABLE V
Disease activity and initial autoantibody titers of
sera from patients with pemphiqus and bullous
pemphigoidt
Widespread
Pemphigus
Pemphigoid
Moderate
Pemphigus
Pemphigoid
Localized
Pemphigus
Pemphigoid
Inactive and/or
adequately
treated
Pemphigus
Pemphigoid
* Normal human skin used as substrate in the
indirect immnnofiuorescent test.
t Highest dilution which yielded a positive test.
Three of these patients had only mouth
lesions.
antibodies of 1: 160 had a titer of 1:20 when
his skin disease improved with therapy. Three
months after therapy began his skin showed
only two small vesicles and his serum antibody
titer was 1:10. Another patient with widespread
pemphigus foliaceus was treated to hematologic
toxicity with azathioprine (Imuran) with only
slight clinical improvement. Her serum "pem-
phigus antibody" titer decreased from 1:320
to 1:80 during this time. She was then treated
with high doses of prednisone (160 mg/day)
for four weeks. Again her skin disease improved
slightly and her serum antibody titer decreased
to 1:40.
The clinical serologic correlation of three
other patients are shown in Figures 7—9. While
under treatment with prednisone patient T.R.'s
serum "pemphigus antibody" titer decreased
(Fig. 7). This was followed by the complete
healing of her skin. Her prednisone require-
ment could be markedly reduced without caus-
ing an exacerbation of the disease. She later had
mouth lesions which regressed without treat-
ment. She had a negative immunofluorescent
test at this time. In the patient W.G. (Fig. 8)
the skin changes had regressed completely,
even before her "pemphigus antibody" titer had
reached the low level of 1: 10. An exacerbation
of the skin disease was preceeded by a rise in
nntibody titer. In the patient MN. (Fig. 9) the
lowering of the "pemphigus antibody" titer
was paralleled by the healing of the skin dis-
ease. For several weeks this patient developed
no skin or mucous membranes lesions although
his serum antibody titer was 1:40. When he
again developed a few skin lesions his serum
antibody titer remained unchanged.
DISCUSSION
Although the antiepithelial autoantibodies in
sera of patients with pemphigus and pemphi-
goid are not species specific, human skin is the
natural substrate they can react with. In most
studies heterologous epithelia were used for the
detection of such antiopithelial antibodies.
We found human skin to be more sensitive
than rabbit esophagus because it allowed for
the detection of lower serum antibody titers. In
addition, human skin retained reactivity with
these antibodies for a longer time than the epi-
thelium of rabbit esophagus. The human skin
was much easier to interpret for positive or
Serum titer
Neg
2 2 2
3 1
11
1 1
23
4
1
1
1+
0
NEW LESION
yes no 300
240
PREDNISONE 180
ng/Day 120
DAY
FIG. 7. Clinical-serologic..therapeutic correlation of patient (T.R) with pemphigus.
Clinical Activity
1+ One to four small lesions with or without mouth lesions or widespread lesions almost
entirely healed.
2+ Few areas with several lesions or widespread lesions partly healed.
3+ Many large areas of involvement or widespread lesions with early signs of healing.
4+ Almost entire body covered with lesions.
CLINICAL
ACTIVITY
0
FIG. 8. Clinical-serologic-therapeutic correlation of patient (W.G.) with pemphigus.
negative antibody binding by means of the im-
munofluorescent test than was rabbit esopha-
gus, especially when determining antibody
titers. Human skin is also an attractive sub-
strate to use since it is the most readily avail-
able material in most dermatologic facilities.
However human volunteers are not essential
since 24 hour old skin from cadavers or skin
from amputated limb is as sensitive as fresh
human skin.
In most of the previous immunofluorescent
studies of bullous disease, skin was used as the
substrate to detect in vivo bound antibody
(direct immunofluorescent test) (10). Waldorf
discussed some of the problems of using skin as
the substrate for indirect immunofluoreseent
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FIG. 9. Clinical-serologic-therapeutic correlation of patient (M.N.) with pemphigus.
staining; the nonspecific fluorescence of the
stratum corneum and dermis, the quenching of
immunofluorescence by skin with a high mel-
anin content, and the need to use acanthotie
epidermis (2). We have obviated these prob-
lems by cutting the skin sections horizontally.
This gives an artifactually "acanthotic" epi-
dermis and islands of superficial dermis sur-
rounded by basement membrane within the
epidermis. This thick epidermis and increased
amounts of basement membrane also minimize
the appearance of nonspecific fluorescence of
the stratum corneum as well as the dermis. Al-
though skin with high melanin content
quenched fluorescence in the basal cell layer it
had no effect on the fluorescence of the rest of
the specimen. In accordance with the observa-
tions of others, we found that though "pemphi-
gus type" immunofluorescence occurred through-
out the entire epidermis, it was most prominent
in the prickle cell layer.
We found that the commercially obtainable
fluorescein isothiocyanate tagged goat anti-hu-
man immunoglobulin was as effective as our
own preparations.
Our results show that neither of the two sub-
strates, human skin or rabbit esophagus yielded
identical results in regard to antibody titers. A
one-fold difference in titer is common; two-fold
differences are infrequent. To minimize varia-
bility, we suggest that comparisons of sera ob-
tained from the same patient should all be
tested together on one day and on the same
substrate,
To our knowledge, the antiepithelial auto-
antibodies in all of the patients with pemphi-
gus and pemphigoid are of the gamma G class.
None of the sera of our pemphigus patients
had a concomitant antinuclear antibody as did
several in Peck's study (5).
In accordance with Chorzelski et at. (4) and
Peck et at. (5), we also observed a good cor-
relation between the initial antiepithelial anti-
body titer and the activity of disease in pa-
tients with pemphigus. When following the
clinical course of the diease and the autoanti-
body titers we found that the activity of the
disease was usually reflected by the antibody
titer levels. Therefore sequential titer determi-
nations can be of predictive value for regres.-
sion or for potential aggravation of the disease.
Peck et at. (5) found a poor correlation of
serum antibody titers and the disease activity
in patients with bullous pemphigoid. In Con-
trast to this, we found the titer of basement
membrane antibodies to correlate well with the
activity of disease in our eight patients with
pemphigoid. We treated one patient with
bullous pemphigoid whose serum antibody titer
decreased while his skin disease improved.
Several of our pemphigoid patients initially
were diagnosed as suffering from dermatitis
herpetiformis (D.H.). The histopathologic skin
changes were compatible with either der-
matitis herpetiformis, pemphigoid, or bullous
erythema multiforme. Their skin disease did
not improve with dapsone or sulfapyridine
therapy but improved when they were treated
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with corticosteroids. On this basis the diagnosis
of pemphigoid was made. Subsequently the
presence of "pemphigoid type" antiepithelial
antibodies was detected in their sera. Pub-
lished data indicate that to date over 100 pa-
tients with pemphigoid and D.H. have been
studied for "pemphigoid type" serum antibodies.
Sixty percent of patients with the clinical diag-
nosis of pemphigoid had such antibodies. How-
ever, their disease activity was not stated. In
this report 100 percent of patients with active
pemphigoid had antiepithelial antibodies. The
higher incidence of such antibodies in our study
may be explained by the use of the more sensi-
tive human skin as assay substrate. Alterna-
tively, the other studies may have included
many patients with inactive disease. None of
our patients who responded favorably to a treat-
ment with dapsone or sulfapyridine had circu-
lating "pemphigoici type" antibodies.
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